Olmesartan HCT Tablet 10/40/12.5 mg

Adult dose

This medication is taken once daily, with or without food, with water. It is recommended to take it at the same time each day (e.g., in the morning). The recommended dosages are as follows: - 5/20/12.5 mg: Given to patients whose blood pressure is not adequately controlled with the Amlodipine/Olmesartan Medoxomil 5/20 mg combination therapy. - 5/40/12.5 mg: Given to patients whose blood pressure is not adequately controlled with the Amlodipine/Olmesartan Medoxomil 5/40.

Child dose

Safety and efficacy in pediatric patients under 18 years have not been established, so its use is not recommended.

This medication can cause serious harm to fetuses and newborns during the second and third trimesters of pregnancy, so it should be discontinued immediately if pregnancy is confirmed. It should not be used in patients with allergies to any of the ingredients or similar medications, those who are pregnant or breastfeeding, or in patients with severe hypotension or cardiac and kidney diseases. Patients with decreased blood volume or electrolyte imbalances may experience hypotension, so their condition should be closely monitored before starting this medication. Patients with impaired kidney function, those who have undergone kidney transplants, severely impaired liver function, or those with certain heart valve diseases should also use this medication cautiously. This medication has blood pressure-lowering effects and may cause dizziness or orthostatic hypotension, so care should be taken when driving or operating hazardous machinery. While taking this medication, electrolyte levels and kidney function should be regularly monitored to ensure no abnormalities occur. This medication may interact with other drugs, so patients taking Lithium, non-steroidal anti-inflammatory drugs (NSAIDs), or other antihypertensives should consult their doctor or pharmacist. Use during breastfeeding is not recommended, and if necessary, breastfeeding should be discontinued or medication use should be suspended. It is advisable not to use this medication in children under 18 years of age, as safety and efficacy have not been established. In case of overdose, severe hypotension and heart problems may occur, requiring immediate medical attention.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, paleness, severe rash with fever, blisters, skin peeling, pain in mouth/eye mucosa, shortness of breath or difficulty breathing, asthma attack, respiratory abnormalities accompanied by cough and fever, yellowing of skin or eyes (jaundice), extreme lethargy, sudden severe headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis, urination abnormalities.

Mild side effects

• Peripheral edema
• headache
• dizziness
• upper respiratory infection
• nasopharyngitis
• urinary tract infection
• sialadenitis
• leukopenia
• thrombocytopenia
• bone marrow suppression

This medication should be stored in a tightly sealed container to prevent exposure to air and moisture. It is important to keep the storage temperature between 1 degree and 30 degrees Celsius. This will safely preserve the drug's efficacy.

Appearance

Round film-coated tablets, reddish color

Package unit

30 tablets/box (10 tablets/Alu-Alu×3)